Skip to content
Traceability first — every claim on this site is published only once substantiated
PEPTIDERESEARCH
Information onlyCOA pending

Semax 10mg + Selank 10mg

Also referenced as: semax selank · research · semaxselank · cognitive research

Combination of Semax and Selank intended for research into cognition, stress resilience and neuropeptide signalling. Project catalogue identifies Semax 10mg + Selank 10mg. This product is supplied in the project catalogue as 10mg + 10mg (20mg total). Supplier availability or commercial vial strength should not be interpreted as a clinical dose or evidence of therapeutic efficacy. For laboratory research use only. Not intended for human consumption.

Research categories

Fields of laboratory research only. Not therapeutic claims, indications or evidence of efficacy.

Not currently held in stock

This specification is not currently in stock. Submit a pre-order and we confirm availability and pricing by email from orders@peptideresearch.au before any payment is taken. Pre-orders receive a 10% discount off the confirmed price.

Specification
10mg + 10mg
Form
Lyophilised powder or solution as supplied
Purity
[INFORMATION REQUIRED]
Purity method
[INFORMATION REQUIRED]
Identity method
[INFORMATION REQUIRED]
Batch
PR-2608
Lot
PR-2608-SXSL10
Storage
[INFORMATION REQUIRED]
Stock
Out of stock

Technical record

Documentation policy

Peptide Research publishes analytical values only where a certificate exists for the lot in question. Where a field reads pending, no verified source document has been supplied — we do not substitute typical or supplier-marketing values.

No human-use information

No dosage, reconstitution-for-administration, protocol or therapeutic-outcome information is published for any record on this site.

Related records